PPT-Measles and Rubella Initiative Financial Resource Requirements for 2015-2020

Measles and Rubella Annual Partners Meeting September 1516 2015 Background The MRI FRR is developed by the MampRI FRRRMAWG Country population data is drawn from UNDP estimates Vaccine type and timing of SIAs is from countries . . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. Panel 01502. Vicki Stambos. The 13. th. Global Measles and Rubella Laboratory Network Meeting, Geneva, Switzerland, 29. th. June to 1. st. July 2015. Vicki Stambos. Accelerating Progress Towards Measles and Rubella Control and Elimination Meeting. Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. . Mona Aryal. HOD, Health Service Department. Nepal Red Cross Society. National Headquarter. . Nepal Red Cross Society’s Initiative. Vision: . to . provide immediate relief to human suffering and reduce vulnerability, under the Fundamental Principles of the Red Cross, . M&RI Partners’ Meeting. Michael F Thomas, . Director Vaccine Implementation. September 2017, Washington DC. Page: . 1. Reach every child. . Measles and Rubella support in Gavi countries by end of 2016. Dr. Khin Devi Aung. Gavi Secretariat. 21. . June 2016, Geneva. 1. #. vaccineswork. AGENDA. About Gavi, the Vaccine Alliance. Gavi’s. support to countries. Gavi’s. 2016-2020 Strategy. Gavi’s. 2020. . Summary of the . Findings . and Implementation Status . Dr Kaushik . Banerjee. M&RI Partners' Meeting. Washington DC. 7 September 2017. 1. Objectives . of . the Review. To provide a candid review of progress . South East Asia Region. 1. 21 June 2016. Geneva, Switzerland. Regional Measles and Rubella Goals. 66th Meeting of the SEAR Regional Committee in September 2013 in New Delhi resolved . to adopt . the goal of . Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. MEA R) VACCINE What is the measles, mump and rubella (MMR) vaccine? The MMR vaccine protects against three diseases: measles, mumps and rubella (german measles). The vaccine is approved by He alth C Accelerating Progress Towards Measles and Rubella Elimination. 23 June 2016. Geneva. , Switzerland. Minal K. Patel WHO HQ IVB/EPI. Background. Growing demand for periodic cross-sectional surveys to identify population immunity gaps.  .  . Frequently Asked Questions. For Use of Teachers. Government of India has decided to introduce. measles-rubella (MR). vaccine. . The vaccine will be launched through a campaign,. to be followed by inclusion of the MR vaccine.